Fannin Innovation Studio
Houston-based early-stage life-sciences development studio (est. 2014) that in-licenses, develops, and incubates therapeutic and medical device assets. Operates a studio team that de-risks technologies with grant and investor funding, spins programs into standalone companies, and provides investor co-investment opportunities and training programs for early-career scientists.
Industries
N/A
Products
Procyrion (Aortix percutaneous circulatory support device)
Portfolio medical-device company developing a percutaneous mechanical circulatory support device; referenced pivotal IDE and clinical trials.
Pulmotect (inhaled immune-stimulatory therapeutic)
Clinical-stage inhaled therapeutic intended to stimulate innate immunity to prevent pulmonary infection; referenced Phase 2 trials.
Brevitest (CLIA laboratory and rapid testing platform)
CLIA-certified clinical laboratory leveraging automation and cloud computing to deliver rapid laboratory-quality results.
Allterum Therapeutics (therapeutic antibody programs)
Biopharmaceutical portfolio company developing monoclonal antibody therapeutics for oncology indications, including programs that have received grant funding and regulatory milestones.
Procyrion (Aortix percutaneous circulatory support device)
Portfolio medical-device company developing a percutaneous mechanical circulatory support device; referenced pivotal IDE and clinical trials.
Pulmotect (inhaled immune-stimulatory therapeutic)
Clinical-stage inhaled therapeutic intended to stimulate innate immunity to prevent pulmonary infection; referenced Phase 2 trials.
Brevitest (CLIA laboratory and rapid testing platform)
CLIA-certified clinical laboratory leveraging automation and cloud computing to deliver rapid laboratory-quality results.
Allterum Therapeutics (therapeutic antibody programs)
Biopharmaceutical portfolio company developing monoclonal antibody therapeutics for oncology indications, including programs that have received grant funding and regulatory milestones.
Services
Studio-managed early-stage development and incubation
End-to-end de-risking and program management for early therapeutic and device assets, including preclinical strategy, operational execution and spin-out formation.
Licensing, in-licensing and spin-out formation
Structuring in-licenses and forming new companies to advance assets beyond studio-stage development.
Grant writing and funded program support
Preparation and submission of grant proposals and administration of grant-funded development work.
Investor relations and co-investment platform
Programmatic co-investment vehicle enabling accredited investors to co-invest in studio spin-outs with deal-level discretion and no ongoing management fees.
Clinical and regulatory strategy support
Regulatory planning and operational support for IND/IDE-enabling activities, early-phase trial initiation and regulatory submissions.
Internship and Product Development Associate programs
Structured experiential training programs providing hands-on experience in therapeutics and medical-device commercialization, with didactic supplements.
Studio-managed early-stage development and incubation
End-to-end de-risking and program management for early therapeutic and device assets, including preclinical strategy, operational execution and spin-out formation.
Licensing, in-licensing and spin-out formation
Structuring in-licenses and forming new companies to advance assets beyond studio-stage development.
Grant writing and funded program support
Preparation and submission of grant proposals and administration of grant-funded development work.
Investor relations and co-investment platform
Programmatic co-investment vehicle enabling accredited investors to co-invest in studio spin-outs with deal-level discretion and no ongoing management fees.
Clinical and regulatory strategy support
Regulatory planning and operational support for IND/IDE-enabling activities, early-phase trial initiation and regulatory submissions.
Internship and Product Development Associate programs
Structured experiential training programs providing hands-on experience in therapeutics and medical-device commercialization, with didactic supplements.
Expertise Areas
- Early-stage product development and de-risking
- Clinical trial management and clinical operations
- Biologics and therapeutic antibody development
- Medical device development and commercialization
Key Technologies
- Monoclonal antibody therapeutics
- Aptamer-based discovery platforms
- Radiopharmaceutical targeting vectors
- Percutaneous mechanical circulatory support devices